Skip to main navigation Skip to search Skip to main content

Prognostic value of baseline PSMA PET/CT for survival in synchronous metastatic hormone-sensitive prostate cancer: Towards redefining low- and high-volume disease

  • Fleur Kleiburg*
  • , Linda Heijmen
  • , Annemieke Witteveen
  • , Kiki van Duuren
  • , Paul Zuidgeest
  • , Frits Smit
  • , Lioe-Fee Oei
  • , Tom van der Hulle
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalEuropean radiology
Publication statusSubmitted - 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Risk Stratification
  • Tumour Volume
  • mHSPC
  • Overall Survival
  • Prostate Cancer
  • PSMA PET/CT

Cite this